CT-REQ-3498 Elections Outlook Report 01 TW - Flipbook - Page 52
Trump Administration Health Care Executive Outlook
Deep FDA Reform
Investigative Commission on Childhood Illnesses
Donald Trump has pledged to appoint Robert Kennedy Jr. as a potential
“health czar” to oversee public health agencies, indicating a re-evaluation
of food safety and conflicts within the agencies. Kennedy has suggested
reorganizing public health agencies by replacing career senior staff and reprioritizing chronic care.
Trump plans to establish a commission of independent experts to
investigate the root causes of childhood illnesses, granting Kennedy
significant authority to address these issues.
NIH Reorganization
President Trump aims to elevate U.S. scientific and clinical research,
potentially through structural changes at NIH that may align with plans
proposed by Republican leadership in the House Energy & Commerce
Committee during the 118th Congress.
Health Technology
The Trump administration is expected to support health technology with an
emphasis on American innovation and cost-efficiency. In health AI, a review
of recent HHS rules, including those requiring AI developers to report on
safety and bias, may occur, with potential rescissions. Broader leeway on
health tech coverage decisions and a faster commercialization pace are
anticipated, along with progress on cybersecurity.
Domestic Manufacturing
The Trump administration is expected to support incentives for domestic
medical manufacturing while penalizing companies that off-shore
operations or rely heavily on imports through tariffs and taxes, building on
Congressional efforts to promote local job creation.
Biosecurity
With bipartisan support for the BIOSECURE ACT in the 118th Congress, a
significant push for biosecurity measures and anti-China regulations in
biotech and biopharma is anticipated, likely including restrictions on data
transfer and collaboration with foreign partners.
